Presentation given by Professor Sophie Witter at the 5th Meeting of the Montreux Collaborative on Fiscal Space, Public Financial Management and Health Financing in November 2021
This is my updated lecture on leadership in Public Health, given to postgraduate students in public health and pharmacy at the University of Hertfordshire.
The presentation begins with a brief history of how cancer epidemiology evolved, and what is the status at present. After describing the burden of the disease of cancer globally and in India, the presentation includes a brief description of Cancer causes and prevention including screening activities. It also talks about the national Cancer Registry Program, NPCDCS and NCCP.
Published in The Lancet in November 2018, GBD 2017 provides for the first time an independent estimation of population, for each of 195 countries and territories and the globe, using a standardized, replicable approach, as well as a comprehensive update on fertility. GBD 2017 incorporates major data additions and improvements, using a total of 68,781 data sources in the estimation process.
This is my updated lecture on leadership in Public Health, given to postgraduate students in public health and pharmacy at the University of Hertfordshire.
The presentation begins with a brief history of how cancer epidemiology evolved, and what is the status at present. After describing the burden of the disease of cancer globally and in India, the presentation includes a brief description of Cancer causes and prevention including screening activities. It also talks about the national Cancer Registry Program, NPCDCS and NCCP.
Published in The Lancet in November 2018, GBD 2017 provides for the first time an independent estimation of population, for each of 195 countries and territories and the globe, using a standardized, replicable approach, as well as a comprehensive update on fertility. GBD 2017 incorporates major data additions and improvements, using a total of 68,781 data sources in the estimation process.
Brief introduction to the One Health concept, and beyondILRI
Presentation by Alexandre Caron, Hélène de Nys, Alexandre Hobeika and Vladimir Grosbois at the Capacitating One Health in Eastern and Southern Africa (COHESA) partner orientation workshop, 16 December 2021.
For Colorectal Cancer Awareness Month, CCSN welcomed back Helene Hutchings to discuss anal and colorectal cancer in this educational webinar. Helene discussed the symptoms & risk factors of these cancers, as well as treatment options that are available.
She also discussed prevention of anal and colorectal cancers and the benefits of peer-to-peer support groups.
There was a Q&A session following the webinar.
Presented by Ghassan Karem.
Part of a session - 'Context, gender, and sustainability in introducing and scaling-up essential health care packages in fragile and crisis-affected countries' - at the Fifth Global Symposium for Health Systems Research in October 2018. The essential package of health services is a mechanism for expanding equitable coverage of primary health care and essential hospital services in countries recovering from conflict. The session explored the evidence-base on such healthcare packages in different contexts and prioritized areas for strengthening research.
My Guest Lecture at Mahamicron 2014 - XX Maharashtra Chapter Conference of the Indian Association of Medical Microbiologists, Nagpur, 19/09/2014 to 21/09/2014.
Dr Rajesh Karyakarte Delivered this Guest Lecture on 21/09/2014 at 9:30 AM.
Brief introduction to the One Health concept, and beyondILRI
Presentation by Alexandre Caron, Hélène de Nys, Alexandre Hobeika and Vladimir Grosbois at the Capacitating One Health in Eastern and Southern Africa (COHESA) partner orientation workshop, 16 December 2021.
For Colorectal Cancer Awareness Month, CCSN welcomed back Helene Hutchings to discuss anal and colorectal cancer in this educational webinar. Helene discussed the symptoms & risk factors of these cancers, as well as treatment options that are available.
She also discussed prevention of anal and colorectal cancers and the benefits of peer-to-peer support groups.
There was a Q&A session following the webinar.
Presented by Ghassan Karem.
Part of a session - 'Context, gender, and sustainability in introducing and scaling-up essential health care packages in fragile and crisis-affected countries' - at the Fifth Global Symposium for Health Systems Research in October 2018. The essential package of health services is a mechanism for expanding equitable coverage of primary health care and essential hospital services in countries recovering from conflict. The session explored the evidence-base on such healthcare packages in different contexts and prioritized areas for strengthening research.
My Guest Lecture at Mahamicron 2014 - XX Maharashtra Chapter Conference of the Indian Association of Medical Microbiologists, Nagpur, 19/09/2014 to 21/09/2014.
Dr Rajesh Karyakarte Delivered this Guest Lecture on 21/09/2014 at 9:30 AM.
In this Thursday, July 12, 2012 webinar, presentations focused on learning more about program requirements, preferences, and other keys to success from CMS Innovation Center staff and communities currently participating in the CCTP program. The final CCTP review panel for 2012 convened on September 20, 2012. Applications must have been received by September 3rd to be considered for this review. Future panels may be announced as funding permits.
- - -
CMS Innovation Center
http://innovation.cms.gov
We accept comments in the spirit of our comment policy:
http://newmedia.hhs.gov/standards/comment_policy.html
CMS Privacy Policy
http://cms.gov/About-CMS/Agency-Information/Aboutwebsite/Privacy-Policy.html
Section27 Health Reform Brief 1 July 2013Section 27
SECTION27 is proud to launch its Health Reform Briefs in an effort to broaden discussion about the different ways in which the health sector is changing. The briefs will look at reform in the health care sector through the lens of the Constitution and public interest, tying together economics, health systems theory and the law.
The first edition focuses on the design of NHI pilots. These briefs will be published every six weeks or so. If you would like to continue receiving these briefs, please send an email to: info@section27.org.za. And please share widely with others you think might be interested.
Presentation from Professor Sophie Witter at the Institute of Development Studies' learning session 'Health financing priorities in the time of Covid-19?'
A critical analysis of purchasing mechanism in China's Rural Health Insurance...resyst
This presentation was given at the International Health Economics Association (iHEA) World Congress in Milan, in July 2015. It includes results and policy implications from the RESYST Purchasing Study conducted in China.
A presentation entitled 'Exploratory review of financial autonomy at primary care level', given by Professor Sophie Witter at the 6th Meeting of the Montreux Collaborative Conference
Can strategic purchasing of health services from the private sector drive val...Rebekah McKay-Smith
Can strategic purchasing of health services from the private sector drive value for money? Evidence from the Results Based Financing programme in Malawi
A presentation by Bruno Meessen, delivered during "Transforming Health Systems Through Results-Based Financing," an event held during the Third Global Symposium on Health Systems Research in Cape Town on September 30, 2014.
Health system strengthening – what is it, how should we assess it, and does i...ReBUILD for Resilience
This presentation was given to the UK's Department for International Development on 30th July 2019.
Comprehensive reviews of health system strengthening interventions are rare, partly because of lack of clarity on definitions of the term but also the potentially huge scale of the evidence. In our talk, we will reflect on the process of undertaking such an evidence review for DFID recently (attached again), drawing out suggestions on definitions of HSS and approaches to assessment, as well as summarising some key conclusions from the current evidence base. Most HSS interventions have theories of change relating to specific system blocks, but more work is needed on capturing their spill-over effects and their contribution to meeting over-arching health system process goals. We will make some initial suggestions about such goals, to reflect the features that characterise a ‘strong health system’. We will highlight current findings on ‘what works’ but also that these are just indicative, given the limitations and biases in what has been studied and how, and argue that there is need to re-think evaluation methods for HSS beyond finite interventions and narrow outcomes. Clearer concepts, frameworks and methods can support more coherent HSS investment.
Sustainable financing of health and social services: Good health at low cost ...OECD Governance
This presentation was made by Mark Blecher, South Africa, at the 10th OECD-Asian Senior Budget Officials Annual Meeting held in Bangkok, Thailand, on 18-19 December 2014.
Lessons from pfm in the health sector finalHFG Project
Over the past five years, the Health Finance and Governance (HFG) project has supported over 35 countries and programs in their efforts to strengthen public financial management (PFM) systems. Activities have been tailored to address key priorities within a health system context, and have ranged from improving financial data systems to conducting costing exercises, financial analyses, and capacity-building workshops. Across these activities, several lessons have emerged.
Insights in this brief stem from analysis of over 200 HFG financing activities; interviews with stakeholders from Ukraine and Vietnam; and experience from cross-cutting program activities. These lessons are shared as a resource for fellow implementing partners, country practitioners, and donor agencies. As the project ends, this brief considers the global context and established frameworks for PFM alongside the contributions of the HFG experience, and suggests a way forward.
Similar to Direct facility financing: rationale, concepts & evidence (20)
Presentation given by Sophie Witter & Christabel Abewe at the 2023 IHEA conference. It was entitled 'Financial protection in Uganda: Reflections from an HFPM assessment'
A presentation given at HSR2022 by Professor Sophie Witter. It looks at:
* What is the evidence on the role of governance for health system strengthening?
* What are the particular challenges for FCAS health systems?
* What is our state of knowledge on governance specifically?
* What are the priorities in relation to governance of the private sector in FCAS?
The comparative agility of the community health worker cadre in fragile & con...ReBUILD for Resilience
In this presentation Joanna Raven explores the comparative agility of the community health worker cadres in four fragile & conflict-affected contexts - Lebanon, Myanmar, Nepal and Sierra Leone.
Health system strengthening evidence review – A summary of the 2021 updateReBUILD for Resilience
A presentation given by Professor Sophie Witter to the UK government's Foreign, Commonwealth & Development Office. This summarises a 2021 review of a health systems strengthening evidence review originally undertaken for the office in 2019.
Paying for performance to improve the delivery of health interventions in LMICsReBUILD for Resilience
This presentation from Sophie Witter & Karin Diaconu of Queen Margaret University, UK outlines the findings from a Cochrane review undertaken by the team on paying for performance to improve the delivery of health interventions in low and middle-income countries.
Performance-based financing presentation to the Health Financing AcceleratorReBUILD for Resilience
A presentation to the Health Financing Accelerator and the Global Fund in March 2021 on the challenges and opportunities for international agencies investing in performance-based financing and direct facility financing in fragiole and conflict-affected settings and low income settings. By Sophie Witter, Maria Bertone & Karin Diaconu of Queen Margaret University, UK.
Understanding Iraq’s BHSP: Examining the Domestic and External Politics of Po...ReBUILD for Resilience
Presented by Goran Abdulla Sabir Zangana, Health Policy Research Organisation, Iraq.
Part of a session - 'Context, gender, and sustainability in introducing and scaling-up essential health care packages in fragile and crisis-affected countries' - at the Fifth Global Symposium for Health Systems Research in October 2018. The essential package of health services is a mechanism for expanding equitable coverage of primary health care and essential hospital services in countries recovering from conflict. The session explored the evidence-base on such healthcare packages in different contexts and prioritized areas for strengthening research.
Context, gender and sustainability in introducing and scaling-up essential he...ReBUILD for Resilience
Presented by Egbert Sondorp of KIT Royal Tropical Institute, Netherlands.
Part of a session - 'Context, gender and sustainability in introducing and scaling-up essential health care packages in fragile and crisis-affected countries' - at the Fifth Global Symposium for Health Systems Research in October 2018. The essential package of health services is a mechanism for expanding equitable coverage of primary health care and essential hospital services in countries recovering from conflict. The session explored the evidence-base on such healthcare packages in different contexts and prioritized areas for strengthening research.
Gender and Essential Packages of Health Services: Exploring the Evidence BaseReBUILD for Resilience
Presented by Val Percival of Norman Paterson School of International Affairs, Carleton University, Canada.
Part of a session - 'Context, gender, and sustainability in introducing and scaling-up essential health care packages in fragile and crisis-affected countries' - at the Fifth Global Symposium for Health Systems Research in October 2018. The essential package of health services is a mechanism for expanding equitable coverage of primary health care and essential hospital services in countries recovering from conflict. The session explores the evidence-base on such healthcare packages in different contexts and prioritizes areas for strengthening research.
The changing health care needs of communities and health systems responses in...ReBUILD for Resilience
Presentation given by Tim Martineau as part of a Satellite Session at the Fifth Global Symposium on Health Systems Research on 9th October 2018: 'No longer invisible - finally bridging the divide between health care, social and societal engagement to build systems for health', organised by CORE Group and Save the Children.
The changing health care needs of communities and health system responses in ...ReBUILD for Resilience
Presentation given by Tim Martineau of Liverpool School of Tropical Medicine, UK and the ReBUILD Consortium on health systems in fragile settings and their changing needs.
Presented as part of a session at the Fifth Global Symposium for Health Systems Research - 'No Longer Invisible - finally bridging health care, social and societal engagement to build systems for health' in October 2018.
Performance based financing as a way to build strategic purchasing in fragile...ReBUILD for Resilience
Presentation given by Sophie Witter at a Satellite Session on "Payment for Performance, how, why, where and what?", at the Fifth Global Symposium on Health Systems Research in Liverpool, on 9th October 2018.
Etat des connaissances sur le renforcement des systèmes de santé dans les con...ReBUILD for Resilience
Presentation (French language) on the state of knowledge on health systems in fragile contexts, given by Professor Sophie WItter at an International Workshop at the Institute of Tropical Medicine in Antwerp on 16th October 2018.
Investigating results based financing as a tool for strategic purchasing _ Co...ReBUILD for Resilience
Presentation given by Maria Paula Bertone at a Satellite session of the 5th Global Symposium on Health Systems Reseach, on "Payment for Performance, how, why, where and what? Learning from research across income settings. Tuesday 9th October 2018.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Explore our infographic on 'Essential Metrics for Palliative Care Management' which highlights key performance indicators crucial for enhancing the quality and efficiency of palliative care services.
This visual guide breaks down important metrics across four categories: Patient-Centered Metrics, Care Efficiency Metrics, Quality of Life Metrics, and Staff Metrics. Each section is designed to help healthcare professionals monitor and improve care delivery for patients facing serious illnesses. Understand how to implement these metrics in your palliative care practices for better outcomes and higher satisfaction levels.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
Direct facility financing: rationale, concepts & evidence
1. Direct facility financing:
rationale, concepts &
evidence
Professor Sophie Witter
Queen Margaret University Edinburgh & ReBUILD for Resilience
17 November 2021, Montreux meeting
3. Background and problem statement
1. Funds are not getting to frontline providers,
especially in primary care
2. This pushes costs onto users
3. Primary care is underfunded, seen as poor quality,
bypassed by users
Driven largely by:
◦ resource shortages
◦ political economy (favouring higher level
facilities)
◦ system failures (weak PFM, capacity gaps)
◦ low levels of trust in managers
Funding source
% of total
Budget User fees Other
4
regional hospitals
62 37 1
6
district health
centres
57 42 1
9
health posts
5 95 0
Source: my PhD fieldwork in Senegal, 2005
4. So why DFF?
DFF not only approach to these challenges but tries to address some of these root causes. Works
on the principle that:
1. Funds should be concentrated where they are needed most – i.e. health facility levels
2. District and provincial level involvement in fund administration creates unnecessary
transaction costs and payment delays, compromising the abilities of facilities to effectively
and efficiently deliver quality health care
3. Needs to be complemented by addressing systemic challenges (ensuring facilities have
flexibility and autonomy and skills to manage etc.)
4. Trust will be built by addressing iteratively addressing blockages and demonstrating results; at
present no accountability can be enforced as resources are not made available; DFF also
usually accompanied by attempts to decrease formal and informal user fees
5. Core concept
Direct facility financing (DFF) = direct provision of funds to health facilities to enable facilities to meet
operational requirements
Basis for payments can vary but commonly prospective (e.g. capitation or budgets-based)
The main differentiating feature is that funds are directly channelled from national levels to health
facilities, and that facilities are given managerial autonomy their use.
◦ Once districts have approved budgets, funds are transferred from national purchasers directly into facility
accounts and facilities can proceed to use funds as agreed, without need for further approvals
◦ Auditing of transaction and expenditure records, as well as usual monitoring and supervision of health facility
activity, are the main verification mechanisms
6. Pre-requisites
DFF requires health facilities to set up independent bank accounts, as well as to have the autonomy (and
capacity) to manage the funds
◦ So willingness to decentralise must be present to some degree
Introduction may be accompanied by:
◦ additional support for budgeting, auditing and accounting, both at district and facility levels (tools +
training + supervision)
◦ specific guidelines and rules for how/when funds obtained via DFF may be spent (e.g. in some countries
purchase of medicines and supplies is excluded to ensure cost-savings and quality control via pooled
procurement mechanisms)
◦ capacity building on community engagement to provide oversight on budgets and fund use
8. Implementation issues
Growing interest but still limited published literature
Studies in Papua New Guinea, Kenya, Tanzania
Kenya: overall spending across the program was high with only few isolated occasions of mismanagement
(e.g. facility fake receipts, in charge absconding with funds)
However, some areas of challenge:
◦ Delays in disbursement
e.g. in Kenya, districts only sent off budgets for approval to national levels once all facilities had
submitted budgets and all funding agreements had to be signed off in Nairobi prior to funds being made
available
◦ Some districts not willing to allow facilities to set budgets
◦ Additional accountancy training needed
9. Impacts
Studies ongoing in Tanzania but preliminary evidence (from Kenya and PNG) suggests:
1. Increased utilisation (though may be due to increased funding)
2. User fees – no strong evidence of reduction
In Kenya, also:
1. Improvements in clinic working environment at facilities (including equipment and
consumables)
2. Increases in staff attendance and outreach services provided
3. Patient-reported improvements in facility cleanliness, waiting times and treatment quality,
including staff courtesy
11. Supportive components
DFF sometimes portrayed as simple but requires considerable groundwork in terms of:
◦ design and implementation of system strengthening components (such as reinforcing management skills at
facility level, access to banking, improved supervision and health information systems);
◦ a broader supportive environment and adequate funding;
◦ programme design and implementation components, such as:
◦ estimating funding amounts which are required at facility level;
◦ determining reporting, verification and performance review approaches;
◦ agreeing, monitoring and enforcing policies on charges to users;
◦ determining and enforcing any rules on staff benefits from the funds, and on how funds can be used more
generally.
Many of these require changes outside health sector, e.g. by MoF
12. DFF can be system strengthening
DFF should be seen as a health system strengthening intervention (not just health financing
intervention), as it impacts on all system areas and should in principle be coherent with arrangements in
them
◦ e.g. health worker remuneration, drug supply systems, governance, public financial management
(PFM) systems, health information systems, service packages, infrastructure quality and distribution,
and measures to address community access barriers
DFF mechanisms of change are also more complex than the label implies: the label focuses on finance,
and resources are indeed important to effects observed. However, there are many other components
which are important
◦ including feedback on effort, signaling of priorities, support for planning, more focus on data and
results and greater autonomy for facility managers, among others
13. Conclusion
◦ It is not a new approach – similar features to approaches
used previously (e.g. for reimbursing lost fees in fee
exemption policies) and in other sectors (e.g. capitated
payments to schools in Uganda)
◦ As a system strengthening intervention, DFF has promise
if designed with good fit to the context and its blockages.
◦ It can provide the small but essential flexible resources
which are needed at facility level to support integrated
care packages
◦ It can contribute to strengthening the system through
encouraging focus on long-term operational constraints
at facility level (skill gaps, rigidities etc.)
◦ It requires complementary interventions at community
level given that it focuses on facility-based services.
14. Questions for panel
1. Do we have a consensus on the definition of DFF?
2. What do grounded experiences tell us about how it is working and lessons
arising, particularly for PFM systems?
3. Where do we need further testing and evidence?
15. References
Witter, S., Bertone, M., Diaconu, K. (2021) Review of Global Fund experience with facility-level performance-based financing
Diaconu, K., Falconer, J., Verbel-Facuseh, A., Fretheim, A., Witter, S. (2021) Paying for performance to improve the delivery of health interventions in low-
and middle-income countries (Review Update). Cochrane Database of Systematic Reviews, Issue 12. Art. No.: CD007899.
Kapologwe NA, Kalolo A, Kibusi SM, Chaula Z, Nswilla A, Teuscher T, et al. Understanding the implementation of Direct Health Facility Financing and its
effect on health system performance in Tanzania: A non-controlled before and after mixed method study protocol. Heal Res Policy Syst. 2019
Waweru E, Goodman C, Kedenge S, Tsofa B, Molyneux S. Tracking implementation and (un)intended consequences: A process evaluation of an innovative
peripheral health facility financing mechanism in Kenya. Health Policy Plan. 2016
Opwora A, Kabare M, Molyneux S, Goodman C. The Implementation and Effects of Direct Facility Funding in Kenya’s Health Centres and Dispensaries.
2009.
Kilwanila H. Process Evaluation on the Implementation of Direct Health Facility Financing ( Dhff ) Programme in Tanzania : a Case of Bukoba Municipal
Council , Kagera , 2019.
Opwora A, Kabare M, Molyneux S, Goodman C. Direct facility funding as a response to user fee reduction: Implementation and perceived impact among
Kenyan health centres and dispensaries. Health Policy Plan. 2010
Wiltshire C, Mako A. Financing health facilites and the free health policy in PNG : challenges and risks. DEVPOLICY BLOG. 2014. p. 1–9.
Cairns A, Witter S, Hou X. Exploring factors driving the performance of rural health care in Papua New (World Bank Policy Note). 2018.
The World Bank Group. Health financing system assessment: Papua New Guinea. [Internet]. 2017